The estimated Net Worth of Randall Rupp is at least 5.25 百万$ dollars as of 13 April 2007. Randall Rupp owns over 31,250 units of Regeneron Pharmaceuticals stock worth over 4,721,037$ and over the last 21 years Randall sold REGN stock worth over 533,055$.
Randall has made over 9 trades of the Regeneron Pharmaceuticals stock since 2003, according to the Form 4 filled with the SEC. Most recently Randall exercised 31,250 units of REGN stock worth 340,313$ on 13 April 2007.
The largest trade Randall's ever made was exercising 143,750 units of Regeneron Pharmaceuticals stock on 31 October 2006 worth over 1,335,438$. On average, Randall trades about 19,551 units every 93 days since 2003. As of 13 April 2007 Randall still owns at least 4,136 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Randall Rupp stock trades at the bottom of the page.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over 13,084,686,326$ worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth 2,539,854,760$ . The most active insiders traders include Sanofi、Pharma Ag Novartis、Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of 47,694,347$. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth 381,400$.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: